相关实验视频
Updated: Jan 10, 2026

An In Ovo Model for Testing Insulin-mimetic Compounds
Published on: April 23, 2018
在2型糖尿病中诊断胰岛素耐药性的潜在新型代用生物标志物
Helen Jiang1, David Henley2,3, Fang-Xu Jiang4
1Department of Medicine, Northern Health, Melbourne 3076, Victoria, Australia.
胰岛素抵抗 (IR) 的早期诊断对于管理2型糖尿病 (T2DM) 至关重要. 磁共振成像 (MRI) 为红外线检测提供了一个有前途的非侵入性方法,有可能改善T2DM护理.
科学领域:
- 生物医学成像技术 生物医学成像技术
- 代谢疾病 代谢疾病
- 内分泌学 在内分泌学.
背景情况:
- 2型糖尿病 (T2DM) 和肥胖是全球流行病,其特点是胰岛素抵抗 (IR).
- 红外线导致β细胞逐渐衰竭,加剧T2DM和心血管风险.
- 早期IR诊断对于预防β细胞脱差和改善T2DM管理至关重要.
研究的目的:
- 确定用于早期诊断和IR分层的新,可访问,非侵入性和负担得起的工具.
- 探索磁共振成像 (MRI) 衍生生物标志物作为T2DM中IR诊断的潜在替代品.
主要方法:
- 该研究调查了MRI衍生生物标志物作为传统方法的潜在替代品.
- 与黄金标准的高胰岛素-高血糖相比,它具有侵入性和复杂性.
主要成果:
- 磁共振成像 (MRI) 衍生生物标记物显示出潜在的潜力,作为IR的新型代用标记物.
- 这些生物标志物可能为IR诊断提供一种可访问和非侵入性的方法.
结论:
- 来自MRI的生物标志物为T2DM中IR的及时诊断和分层提供了一个有希望的途径.
- 这种方法在T2DM预防和治疗策略中可能具有重要的临床应用.
更多相关视频
07:30Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion
Published on: May 10, 2018
08:13Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Oral Hypoglycemic Agents: Biguanides and Glitazones